Convicted Harvard Scientist rebuilds brain-Computer interface Lab in China

A former Harvard University scientist convicted in the United States for lying about his ties to China has resurfaced at the center of a major state-backed research initiative in Shenzhen, where he is now leading advanced work on brain-computer interface technology. Charles Lieber, once regarded as one of the world’s most influential chemists, is now directing the Institute for Brain Research, Advanced Interfaces and Neurotechnologies (i-BRAIN), part of the Shenzhen Medical Academy of Research and Translation (SMART). The facility is supported by substantial Chinese government funding and is p

A former Harvard University scientist convicted in the United States for lying about his ties to China has resurfaced at the center of a major state-backed research initiative in Shenzhen, where he is now leading advanced work on brain-computer interface technology. Charles Lieber, once regarded as one of the world’s most influential chemists, is now directing the Institute for Brain Research, Advanced Interfaces and Neurotechnologies (i-BRAIN), part of the Shenzhen Medical Academy of Research and Translation (SMART). The facility is supported by substantial Chinese government funding and is positioned within the country’s rapidly expanding neuroscience and semiconductor ecosystem. From Harvard conviction to Shenzhen leadership Lieber, 67, was convicted in 2021 in the United States for making false statements about his connections to China’s Thousand Talents Program and for tax-related offenses tied to payments from a Chinese university. He was sentenced to a short prison term, followed by house arrest and supervised release. Despite the conviction, Lieber has since relocated to China, where he has taken a leading scientific role. At a Shenzhen government event in late 2025, he described his arrival as the beginning of a new phase of his research ambitions, stating that his goal was to help make Shenzhen a global leader in advanced neurotechnology. Focus on brain-computer interfaces Lieber’s new lab focuses on brain-computer interfaces (BCIs), a field that seeks to connect neural activity directly with electronic systems. The technology has potential medical applications, including restoring movement for paralyzed patients or treating neurological disorders such as ALS. However, it also raises concerns due to possible military uses, including enhanced cognition or performance augmentation. The i-BRAIN facility reportedly has access to specialized nanofabrication tools and dedicated infrastructure for animal research, including primate studies—resources that were more limited during Lieber’s tenure at Harvard. Researchers are currently being recruited to conduct electrophysiological studies on rhesus monkeys, which are widely considered a critical step in developing invasive neural interface systems before human trials. Expanding resources and state support The institute operates within a broader network of Shenzhen-backed research centers, including large-scale facilities for neuroscience and semiconductor fabrication. One notable installation is a deep ultraviolet lithography system, similar to those used in advanced chip manufacturing. Funding for SMART, the parent academy, has continued to grow, reflecting China’s strategic emphasis on emerging technologies such as brain-computer interfaces. National policy has identified the field as a key driver of future high-tech development. International talent and scientific strategy Lieber is among several researchers who have moved from U.S. institutions to Shenzhen-based research programs. His appointment highlights China’s broader effort to attract international expertise and accelerate innovation in strategic scientific fields. Experts note that while brain-computer interface research faces regulatory and ethical constraints in the United States—particularly in animal testing and defense-related applications—China’s centralized funding model allows for faster scaling of large experimental programs. Broader implications The case has reignited debate in the United States over scientific security and technology transfer. Analysts argue that even after legal action, researchers with access to sensitive expertise may continue contributing to competing national programs abroad. Critics of U.S. policy suggest that enforcement measures have not fully prevented the global movement of advanced knowledge, particularly in fields with both medical and defense applications. Meanwhile, supporters of international collaboration emphasize that brain-computer interface research is inherently global and depends on shared scientific progress. A contested future for neurotechnology As brain-computer interface research accelerates worldwide, the field is increasingly shaped by both scientific promise and geopolitical tension. Lieber’s new role in Shenzhen places him at the intersection of cutting-edge neuroscience and strategic technological competition between major powers. His work now unfolds in a rapidly expanding research environment that combines state investment, advanced manufacturing capabilities, and large-scale experimental infrastructure—setting the stage for significant developments in the next decade of neurotechnology.